Marin H Kollef (Marin Kollef)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Topics

Multidrug Resistant

Methicillin Resistant Staphylococcus Aureus

Intensive Care Unit

Top Venues

JCO clinical cancer informatics

Infection control and hospital epidemiology

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick G Lyons, Vanessa Chen, Tejas Chellu Sekhar, Colleen A McEvoy, Marin H Kollef, Ramaswamy Govindan, Peter Westervelt, Kelly C Vranas, Thomas M Maddox, Elvin Hsing Geng, Philip Richard Orrin Payne, Mary C Politi
Clinician Perspectives on Barriers and Enablers to Implementing an Inpatient Oncology Early Warning System: A Mixed-Methods Study. JCO clinical cancer informatics 7 (2023)
Patrick G Lyons, Vanessa Chen, Tejas Chellu Sekhar, Colleen A McEvoy, Marin H Kollef, Ramaswamy Govindan, Peter Westervelt, Kelly C Vranas, Thomas M Maddox, Elvin Hsing Geng, Philip Richard Orrin Payne, Mary C Politi
Clinician Perspectives on Barriers and Enablers to Implementing an Inpatient Oncology Early Warning System: A Mixed-Methods Study. JCO clinical cancer informatics 7 (2023)
Richard F Van Besien, Nicholas Hampton, Scott T Micek, Marin H Kollef
Ceftriaxone resistance and adequacy of initial antibiotic therapy in community onset bacterial pneumonia. Medicine 101 (20) (2022)
Andrew F Shorr, Daniel T Ilges, Scott T Micek, Marin H Kollef
The importance of viruses in ventilator-associated pneumonia. Infection control and hospital epidemiology (2022)
Matthew C Bittmann, Scott T Micek, Marin H Kollef
Lack of pathogen identification influencing antibiotic de-escalation in hospital-acquired pneumonia. Antimicrobial stewardship & healthcare epidemiology : ASHE 2 (1) (2022)
Marin H Kollef, Andrew F Shorr, Matteo Bassetti, Jean-Francois Timsit, Scott T Micek, Andrew P Michelson, Jose Garnacho-Montero
Timing of antibiotic therapy in the ICU. Critical care (London, England) 25 (1) (2021)
Dan Reynolds, Marin H Kollef
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update. Drugs 81 (18) (2021)
Besu F Teshome, Scott Martin Vouri, Nicholas Hampton, Marin H Kollef, Scott T Micek
Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance. Pharmacotherapy 39 (3) (2019)
Jason P Burnham, Scott T Micek, Marin H Kollef
Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials. PloS one 12 (7) (2017)